1. Home
  2. AVDL vs GBX Comparison

AVDL vs GBX Comparison

Compare AVDL & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • GBX
  • Stock Information
  • Founded
  • AVDL 2015
  • GBX 1974
  • Country
  • AVDL Ireland
  • GBX United States
  • Employees
  • AVDL N/A
  • GBX N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • GBX Railroads
  • Sector
  • AVDL Health Care
  • GBX Industrials
  • Exchange
  • AVDL Nasdaq
  • GBX Nasdaq
  • Market Cap
  • AVDL 1.5B
  • GBX 1.5B
  • IPO Year
  • AVDL 1996
  • GBX N/A
  • Fundamental
  • Price
  • AVDL $18.57
  • GBX $46.02
  • Analyst Decision
  • AVDL Buy
  • GBX Hold
  • Analyst Count
  • AVDL 10
  • GBX 2
  • Target Price
  • AVDL $18.94
  • GBX $59.50
  • AVG Volume (30 Days)
  • AVDL 4.4M
  • GBX 251.9K
  • Earning Date
  • AVDL 11-11-2025
  • GBX 10-28-2025
  • Dividend Yield
  • AVDL N/A
  • GBX 2.79%
  • EPS Growth
  • AVDL N/A
  • GBX 88.14
  • EPS
  • AVDL N/A
  • GBX 7.10
  • Revenue
  • AVDL $221,075,000.00
  • GBX $3,533,700,000.00
  • Revenue This Year
  • AVDL $64.21
  • GBX N/A
  • Revenue Next Year
  • AVDL $30.80
  • GBX N/A
  • P/E Ratio
  • AVDL N/A
  • GBX $6.47
  • Revenue Growth
  • AVDL 132.35
  • GBX 0.70
  • 52 Week Low
  • AVDL $6.38
  • GBX $37.77
  • 52 Week High
  • AVDL $18.65
  • GBX $71.06
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 79.97
  • GBX 51.44
  • Support Level
  • AVDL $13.83
  • GBX $45.20
  • Resistance Level
  • AVDL $18.65
  • GBX $46.43
  • Average True Range (ATR)
  • AVDL 0.59
  • GBX 1.04
  • MACD
  • AVDL 0.43
  • GBX 0.09
  • Stochastic Oscillator
  • AVDL 97.93
  • GBX 76.23

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: